跳至主要内容
临床试验/JPRN-UMIN000041665
JPRN-UMIN000041665已完成未知

Verification study of the effect of a single intake of the test food on dry eyes and eyestrain - Verification study of the effect of a single intake of the test food on dry eyes and eyestrain

imeQ RD inc.0 个研究点目标入组 12 人开始时间: 2021年9月12日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 50years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Those who are currently receiving some types of drug (except for the drugs that are taken as needed). Cholinergic agonists and anticholinergic drugs are not allowed even for abortive use (e.g., for use in stomach medicine and treatment of hyperhidrosis). 2. Those who have some kind of eye treatment (including dry eye). 3. Those who have had eye surgery within one year of the screening test and those who are planning to have eye surgery (including LASIK surgery) during the study period 4. People with serious or progressive diseases or symptoms (such as those for which drugs are used regularly on a daily basis) 5. Those who take health foods (foods or supplements that affect the body's composition, or are intended to maintain or restore health). 6. Those who have a past and current medical history of drug or food allergy. 7. Those who are participating in or currently participating in another clinical trial within one month prior to obtaining consent. 8. Pregnant, wishing to become pregnant between the screening date and the end of the food study, and breastfeeding 9. Those who regularly take foods containing lactobacillus and who have ingested dairy products (yogurt, kefir, sour cream, cheese, fermented butter, lactic acid bacteria drinks) containing lactobacillus even once within the past 7 days. 10. Those who plan to take dairy products containing lactobacillus (yogurt, kefir, sour cream, cheese, fermented butter, lactic acid bacteria drink) from the screening date to the end of the test period. 11. People with hay fever 12. Those who the investigator has determined to be inappropriate for this study.

研究者

发起方
imeQ RD inc.

相似试验